← FDA Drug Approvals (Drugs@FDA)

OLMESARTAN MEDOXOMIL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL RX · Approved 2024-01-25

Drug application

FDA Application #
ANDA206227
Application type
Abbreviated New Drug Application (Generic)
Brand name
OLMESARTAN MEDOXOMIL
Generic name
Olmesartan Medoxomil
Active ingredients
OLMESARTAN MEDOXOMIL
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
CHARTWELL RX
First approval
2024-01-25

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown